| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/16/2003 | WO2003004601A2 New assays for preimplantation factor and preimplantation factor peptides |
| 01/16/2003 | WO2003004517A2 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | WO2003004466A2 Dye-sulfenates for dual phototherapy |
| 01/16/2003 | WO2003004141A2 Kinase mimic catalysts for asymmetric synthesis of phosphorylated insitols and cycloalkanols |
| 01/16/2003 | WO2003004091A2 Aromatic sulfenates for type i phototherapy |
| 01/16/2003 | WO2003004050A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | WO2002055185A3 Block copolymers for multifunctional self-assembled systems |
| 01/16/2003 | WO2002031109A3 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 01/16/2003 | WO2002014352A3 Therapeutic compounds for ovarian cancer |
| 01/16/2003 | US20030013881 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/16/2003 | US20030013850 Antiinflammatory agents |
| 01/16/2003 | US20030013844 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 01/16/2003 | US20030013677 Anticancer agents |
| 01/16/2003 | US20030013660 Dioxolane analogs for improved inter-cellular delivery |
| 01/16/2003 | US20030013659 Herpes virus |
| 01/16/2003 | US20030013658 Small peptides and methods for treatment of asthma and inflammation |
| 01/16/2003 | US20030013655 Compounds and methods for regulating cell adhesion |
| 01/16/2003 | US20030013645 Central nervous system disorders; Alzheimer's disease; Parkinson's disease |
| 01/16/2003 | US20030013170 Inhibitors of receptor activator of NF-kappaB and uses thereof |
| 01/16/2003 | US20030013169 Transcription factor E2F DNA-binding domain inhibitor peptides and their use |
| 01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
| 01/16/2003 | US20030013077 Binding to monoclonal antibodies; detection of Kaposi's sarcoma |
| 01/16/2003 | CA2452835A1 Aromatic sulfenates for type i phototherapy |
| 01/16/2003 | CA2452628A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | CA2451741A1 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | CA2443644A1 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 01/15/2003 | EP1275728A1 Polyhydroxyalkanoate-containing structure and manufacturing method thereof |
| 01/15/2003 | EP1275657A1 Peptide derivatives and medicinal compositions |
| 01/15/2003 | EP1275396A2 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 01/15/2003 | EP1274724A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 01/15/2003 | EP1274723A2 ACTIVATION OF PEPTIDE PRODRUGS BY hK2 |
| 01/15/2003 | CN1391606A Mimic cellulose binding domain |
| 01/15/2003 | CN1391580A Peptides |
| 01/15/2003 | CN1390848A Bradykinin of Bombina maxima and its preparing process and genes |
| 01/14/2003 | US6506906 Preparation and use of bifunctional molecules having DNA sequence binding specificity |
| 01/14/2003 | US6506875 Diagnostic epitopes |
| 01/14/2003 | US6506731 Elastin peptide analogs and methods of using same |
| 01/14/2003 | US6506726 Purification of an Echinocandin-type compound by adsorption onto a hydrophobic, reversed phase chromatographic media and eluting with a continuous nearly linear gradient of increasing acetic acid |
| 01/14/2003 | US6506558 Deprotecting nucleoside, nucleotide or amino acid to form polypeptide or polynucleotide |
| 01/14/2003 | US6506362 Peptides and peptide mimetics attached to labels and/or hydrophilic polymmers; treating hematological disorders, particularly thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions |
| 01/14/2003 | CA2246758C Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 01/14/2003 | CA2194444C Immunomodulators |
| 01/14/2003 | CA2114313C Bpc peptides, their preparation and use |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | WO2003002596A2 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 01/09/2003 | WO2003002595A2 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 01/09/2003 | WO2003002594A1 Hypoglycaemic peptides and methods of use thereof |
| 01/09/2003 | WO2003002593A2 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 01/09/2003 | WO2003002092A2 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 01/09/2003 | WO2002020558A3 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 01/09/2003 | WO2002008251A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/09/2003 | WO2001081376A3 Apo-ai/aii peptide derivatives |
| 01/09/2003 | WO2001074846A3 Peptides mimicking the biological activity of steroid hormones and their uses |
| 01/09/2003 | WO2001062297A9 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 01/09/2003 | US20030009010 As vaccines for therapy and prophylaxis of Haemophilus influenzae infection |
| 01/09/2003 | US20030008814 Pseudomycin phosphate prodrugs |
| 01/09/2003 | US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 01/09/2003 | CA2452069A1 Hypoglycaemic peptides and methods of use thereof |
| 01/09/2003 | CA2429429A1 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | CA2424645A1 New use of dipeptidyl peptidase iv inhibitors |
| 01/09/2003 | CA2419888A1 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 01/09/2003 | CA2418543A1 New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 01/08/2003 | EP1273591A1 Polypeptide and process for measuring living body components using the same |
| 01/08/2003 | EP1272516A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 01/08/2003 | EP1272515A2 Immunoregulator |
| 01/08/2003 | EP1272510A2 Pharmacologically active antiviral peptides and methods of their use |
| 01/08/2003 | EP1272509A2 Prion-binding peptidic ligands and methods of using same |
| 01/08/2003 | EP1272223A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 01/08/2003 | EP1272215A2 Pharmaceutical preparations comprising modified peptides |
| 01/08/2003 | EP1012175B1 A peptide with an affinity for clotting factor viii |
| 01/08/2003 | CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use |
| 01/08/2003 | CN1390231A Metal-binding compounds and uses thereof |
| 01/08/2003 | CN1390230A Peptides for treatment of erectile dysfunction |
| 01/08/2003 | CN1098274C AZA cyclohexapeptide compounds |
| 01/07/2003 | US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | CA2363780C Radiolabeled compounds for thrombus imaging |
| 01/07/2003 | CA2069154C Polypeptides |
| 01/03/2003 | WO2003001204A2 Type 1 diabetes diagnostics and therapeutics |
| 01/03/2003 | WO2003000731A1 Stereostructural motif and three-dimensional structural coordinate of peptide and utilization thereof |
| 01/03/2003 | WO2003000720A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | WO2003000277A2 Antimicrobial peptides |
| 01/03/2003 | WO2002042449A3 Method for selecting peptide ligands |
| 01/03/2003 | WO2002008187A9 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/03/2003 | WO2002007759A3 Clostridial toxin derivatives and methods for treating pain |
| 01/03/2003 | CA2451328A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | CA2451310A1 Antimicrobial peptides |
| 01/03/2003 | CA2449990A1 Type 1 diabetes diagnostics and therapeutics |
| 01/02/2003 | US20030004114 Method of inhibiting fungal growth |
| 01/02/2003 | US20030004112 Cell-permeable protein inhibitors of calpain |
| 01/02/2003 | US20030004107 Method of preventing cell death using segments of neural thread proteins |
| 01/02/2003 | US20030003449 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 01/02/2003 | US20030003049 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 01/02/2003 | EP1270594A1 Antibodies to peptide from a soluble fragment of acetylcholinesterase |
| 01/02/2003 | EP1270585A1 Peptide derivative |
| 01/02/2003 | EP1269196A1 Method of screening for inhibitors of osteopontin |
| 01/02/2003 | EP1268850A1 Fluorescence detection of proteases or peptidases |
| 01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 01/02/2003 | EP1268756A2 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |